Gsk (GSK) Payout Ratio (2009 - 2026)

Gsk (GSK) has 18 years of Payout Ratio data on file, last reported at 0.46 in Q3 2026.

• For the quarter ending Q3 2026, Payout Ratio changed N/A year-over-year to 0.46; the trailing twelve-month figure through Sep 2026 stood at 0.46 (changed N/A YoY), and the FY2025 full-year result was 0.45, down 52.74% from the prior year.
• Payout Ratio was 0.46 for Q3 2026 at Gsk, up from 0.26 in the prior quarter.
• In the past five years, Payout Ratio ranged from a high of 0.52 in Q2 2022 to a low of 0.18 in Q2 2023.
• A 5-year average of 0.32 and a median of 0.27 in 2024 frame the typical range for Payout Ratio.
• Across the five-year window, Payout Ratio plunged 65.25% in 2023 and soared 88.67% in 2024, its largest moves.
• Gsk's Payout Ratio stood at 0.21 in 2022, then gained by 12.57% to 0.24 in 2023, then soared by 88.67% to 0.45 in 2024, then sank by 43.6% to 0.26 in 2025, then soared by 78.38% to 0.46 in 2026.
• Per Business Quant data, the three most recent Payout Ratio figures were 0.46 in Q3 2026, 0.26 in Q1 2026, and 0.26 in Q4 2025.